Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer

NCT02039791 is registered in ClinicalTrials.gov with Biotech Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02039791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02039791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer
Lead sponsor
Biotech Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2013
Completion date
August 31, 2016
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer